UPDATE : Tuesday, September 17, 2019
상단여백
Hanmi spurs new immunotherapy development through open innovation by Lee Han-soo 2019-09-17 18:14
‘Lundbeck to work with parliament to prevent suicide in Korea’ by Kim Yun-mi 2019-09-17 15:19
Shinpoong's malaria treatment expands global presence by Lee Han-soo 2019-09-17 15:13
SK Bioscience to export influenza vaccine to Asian countries by Lee Han-soo 2019-09-17 11:27
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma by Kim Yun-mi 2019-09-16 16:20
라인
'Roche Korea to put patient accessibility first' by Lee Han-soo 2019-09-16 15:41
GC’s Hunter syndrome drug to get priority screening in China by Lee Han-soo 2019-09-16 13:56
GSK’s chronic hand eczema treatment faces local competition by Lee Han-soo 2019-09-12 07:22
Chong Kun Dang wins patent suit against Novartis over immunosuppressant by Jeong Sae-im 2019-09-11 15:16
AstraZeneca to challenge Roche in small-cell lung cancer treatment market by Kim Yun-mi 2019-09-11 14:18
라인
Amgen fetes 1st anniversary of getting expanded indication for Repatha by Lee Han-soo 2019-09-11 13:56
Hanmi to launch 3-substance combination in Latin America by Lee Han-soo 2019-09-11 13:56
Daewoong to test botulinum toxin Nabota for hair loss by Jeong Sae-im 2019-09-11 13:56
Novartis withdraws suit against Ahngook’s generic drug by Jeong Sae-im 2019-09-10 15:38
Immunotherapies Opdivo, Keytruda score high in real setting by Kim Eun-young 2019-09-10 12:49
라인
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’ by Lee Han-soo 2019-09-09 16:54
Hanmi to unveil investigator-led P2 progress for cancer treatment by Lee Han-soo 2019-09-09 15:47
Novo Nordisk's Ryzodeg leads Korean mixed insulin market by Lee Han-soo 2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019 by Kim Yun-mi 2019-09-09 11:56
Ildong to sell GSK’s influenza treatment by Lee Han-soo 2019-09-06 17:02
여백
여백
여백
Back to Top